CNC 10-Q Quarterly Reports

Centene Corporation (CNC) reported strong financial results for the second quarter and first half of 2026, demonstrating significant year-over-year improvements. Total revenues grew 10% to $53.6 billion for the quarter and 9% to $103.5 billion for the first half, driven by increased premium tax revenue, higher premium yields, and rate adjustments across its Medicaid and Marketplace segments. The company also saw substantial growth in its Medicare Prescription Drug Plan (PDP) business. Profitability improved markedly, with net earnings of $1.09 billion ($2.19 diluted EPS) in Q2 2026, a significant turnaround from a loss in the prior year. For the first half, net earnings were $2.63 billion ($5.30 diluted EPS). This improvement is attributed to a lower Health Benefits Ratio (HBR) of 89.6% in Q2 2026 (down from 93.0% in Q2 2025) and a stable Selling, General, and Administrative (SG&A) expense ratio. The company also managed its debt effectively, repurchasing over $1.3 billion in senior notes during the first half of the year. Overall, Centene appears to be successfully navigating industry challenges and executing its strategic initiatives.

Centene Corporation (CNC) reported a strong first quarter for 2026, demonstrating significant growth in total revenues, up 7% year-over-year to $49.9 billion. This revenue increase was primarily driven by growth in its Medicare Prescription Drug Plan (PDP) business and rate increases in its Medicaid segment, despite a slight overall decrease in managed care membership. The company's profitability also saw a notable improvement, with net earnings attributable to Centene Corporation increasing by 18% to $1.54 billion, and diluted EPS rising to $3.11. Key to this performance was effective cost management, reflected in a slight improvement in the Health Benefits Ratio (HBR) to 87.3% and a decrease in the Selling, General, and Administrative (SG&A) expense ratio to 7.6%. The company also generated substantial operating cash flow of $4.4 billion, indicating strong operational liquidity. Centene's strategic initiatives, including the partial sale of its Part D risk-sharing program receivables and continued focus on integrated care through Dual Eligible Special Needs Plans (D-SNPs), position it well for future growth. However, investors should note the ongoing regulatory changes impacting the healthcare landscape, particularly in the Medicaid and Marketplace segments, which continue to influence membership trends and market dynamics.

Centene Corporation (CNC) reported a significant net loss of $6.63 billion for the third quarter of 2025, primarily driven by a substantial non-cash goodwill impairment charge of $6.7 billion. This impairment was attributed to evolving market conditions, including potential membership impacts from the 'One Big Beautiful Bill Act' and changes in Marketplace enhanced Advance Premium Tax Credits. Despite the GAAP loss, the company reported an adjusted diluted EPS of $0.50, indicating operational profitability excluding the impairment. Total revenues saw robust growth of 18% year-over-year to $49.7 billion, fueled by strong performance in the Prescription Drug Plan (PDP) business, market growth in the Health Insurance Marketplace, and increased Medicaid rates. However, the Health Benefits Ratio (HBR) increased to 92.7% from 89.2% in the prior year, reflecting higher medical costs in Marketplace and Medicaid segments, as well as impacts from the Inflation Reduction Act on the PDP business. The company's strategic focus remains on managing medical costs, adapting to regulatory changes, and driving operational efficiency, as evidenced by an improved SG&A expense ratio.

Centene Corporation (CNC) reported a net loss of $0.51 per diluted share for the second quarter of 2025, a significant decline from the $2.16 earnings per share in the same period last year. This downturn was primarily attributed to a reduction in the estimated net 2025 Marketplace risk adjustment revenue transfer, alongside increased medical costs in both the Marketplace and Medicaid segments. Total revenues saw a substantial 22% year-over-year increase to $48.7 billion, driven by strong performance in the Medicare Prescription Drug Plan (PDP) business and growth in the Health Insurance Marketplace, alongside rate increases in Medicaid. Despite revenue growth, the company's Health Benefits Ratio (HBR) rose to 93.0% from 87.6% in the prior year's second quarter, indicating higher medical costs relative to premium revenues. This was partially offset by an improvement in the Selling, General & Administrative (SG&A) expense ratio to 7.1% from 8.0%, reflecting better cost leverage over increased revenues. The company's liquidity remains solid, with cash flows from operations providing $3.3 billion for the first six months of 2025, and a substantial $1.8 billion remaining under its stock repurchase authorization.

Centene Corporation (CNC) reported strong first-quarter 2025 results, demonstrating robust revenue growth and improved profitability. Total revenues surged by 15% year-over-year to $46.6 billion, driven primarily by significant expansion in the Medicare Prescription Drug Plan (PDP) and Health Insurance Marketplace (Ambetter Health) businesses. Despite a slight increase in the Health Benefits Ratio (HBR) due to seasonal factors in Medicaid, the company effectively managed expenses, leading to a decrease in the SG&A expense ratio and a substantial 39% increase in operating earnings. Net earnings attributable to Centene Corporation rose 13% to $1.31 billion, with diluted earnings per share (EPS) increasing by 22% to $2.63. The company also reported strong operating cash flows of $1.5 billion. Management highlighted strategic wins in contract renewals and expansions across its Medicaid segment, alongside growth in its Medicare and Commercial businesses, positioning Centene favorably for future performance amidst evolving healthcare regulations.

Centene Corporation (CNC) reported a mixed financial performance for the third quarter and first nine months of 2024. Total revenues showed robust year-over-year growth, driven by strong performance in the Commercial (Marketplace) segment and increased premium tax revenue, partially offset by declines in Medicaid membership due to redeterminations and divestitures in the 'Other' segment. While overall revenue grew, the company experienced a higher Health Benefits Ratio (HBR) primarily due to increased acuity in Medicaid and Medicare Star rating impacts, leading to a decrease in gross margin across Medicaid and Medicare segments. Despite these challenges, the company's net earnings and diluted EPS saw significant year-over-year increases for the quarter, though adjusted diluted EPS declined. This improvement in GAAP EPS was aided by lower income tax expense and strong investment income, as well as the absence of significant impairment charges seen in the prior year. The company continues its strategic initiatives, including geographic expansion in its Commercial business and managing its Medicare Advantage strategy despite challenges from Star ratings. Liquidity remains solid, supported by operating cash flows and a substantial stock repurchase program authorization.

Centene Corporation (CNC) reported its second quarter 2024 financial results, demonstrating revenue growth and improved profitability driven by expansion in its Commercial Marketplace business and effective cost management. Total revenues rose by 6% year-over-year to $39.8 billion, with premium and service revenues showing a 3% increase. The company achieved a Health Benefits Ratio (HBR) of 87.6% and an SG&A expense ratio of 8.0%, indicating operational efficiency. Key growth drivers include a 34% year-over-year increase in Commercial Marketplace membership, now available in 29 states, and a 47% surge in Medicare Prescription Drug Plan (PDP) membership. While Medicaid membership saw a decline due to ongoing eligibility redeterminations, Centene is well-positioned to capture members transitioning to other coverage options. The company also reported strong earnings per share (EPS) of $2.16, up from $1.92 in the prior year, and maintained a solid liquidity position with $5.7 billion in working capital.

Centene Corporation (CNC) reported its first quarter 2024 financial results, showcasing solid revenue growth driven by its Commercial Marketplace business. Total revenues reached $40.4 billion, a 4% increase year-over-year, primarily fueled by a 41% membership surge in its Ambetter Health product. Despite overall revenue growth, the company experienced a slight decrease in managed care membership and a nominal increase in the health benefits ratio (HBR) to 87.1%. Net earnings attributable to Centene Corporation were $1.16 billion, or $2.16 per diluted share, an increase from the prior year. The company also highlighted progress in divesting non-core international assets and expanding its Medicaid footprint in various states. Operationally, Centene is navigating the complex landscape of Medicaid redeterminations, which have impacted membership but are expected to see most states conclude by the second quarter of 2024. The company is strategically positioned to capture members transitioning from Medicaid to the Health Insurance Marketplace. While Medicare Advantage revenue saw a decline due to lower Star quality ratings, the Medicare Prescription Drug Plan (PDP) membership saw significant growth. Centene's proactive approach to market changes, ongoing value creation plan, and focus on operational efficiency provide a stable outlook despite regulatory shifts.

Centene Corporation's (CNC) third-quarter 2023 filing indicates a period of revenue growth driven primarily by its Commercial Marketplace business and stable Medicaid operations, partially offset by ongoing divestitures. Total revenues reached $38.0 billion, a 6% increase year-over-year, with Premium and Service revenues growing 4% to $35.0 billion. The Health Benefits Ratio (HBR) improved to 87.0% from 88.3% in the prior year's quarter, signaling better cost management. However, the Selling, General & Administrative (SG&A) expense ratio slightly increased to 8.7% from 8.4%, influenced by the higher-cost Commercial segment. Net earnings attributable to Centene Corporation saw a notable decrease to $469 million ($0.87 diluted EPS) from $738 million ($1.27 diluted EPS) in the prior year's quarter, largely due to significant impairment charges totaling $440 million, including a $251 million charge related to the pending divestiture of Circle Health and a $142 million charge for the Operose Health business. Despite these one-time charges, the company's core operations demonstrate resilience, and its Value Creation Plan, which includes strategic divestitures and cost optimization, is progressing.

Centene Corporation (CNC) reported a strong second quarter for 2023, demonstrating significant year-over-year revenue growth and a substantial increase in net earnings. Total revenues rose by 5% to $37.6 billion, driven by membership gains in the Commercial Marketplace and stable performance in Medicaid, despite ongoing eligibility redeterminations. The company successfully executed on its Value Creation Plan, completing several strategic divestitures and repurchasing $777 million in common stock during the first six months, with an additional $300 million in July. Financially, Centene saw a significant turnaround in profitability, reporting diluted earnings per share of $1.92, a stark contrast to the loss reported in the prior year. This improvement was supported by strong operating cash flows of $2.5 billion for the quarter and strategic divestitures which streamlined operations. The company also highlighted its expanding footprint in the Commercial Marketplace, anticipating continued growth opportunities, and is actively managing the transition of Medicaid members post-PHE redeterminations.

Centene Corporation (CNC) reported strong financial performance for the first quarter of 2023, demonstrating robust revenue growth and improved profitability. Total revenues reached $38.9 billion, a 5% increase year-over-year, driven primarily by growth in its Medicaid and Commercial segments, particularly the Health Insurance Marketplace (Ambetter Health) which saw a significant 52% increase in membership. The company also highlighted a significant improvement in net earnings attributable to Centene Corporation, which rose to $1.13 billion from $849 million in the prior year quarter, translating to a substantial increase in diluted EPS to $2.04 from $1.44. This growth was supported by effective cost management, a favorable health benefits ratio (HBR) of 87.0%, and a strategic focus on operational efficiencies outlined in their Value Creation Plan. The successful divestiture of non-core businesses, including Magellan Specialty Health, Centurion, and HealthSmart, has streamlined operations and is expected to contribute to future margin expansion.

Centene Corporation (CNC) reported a solid third quarter for 2022, demonstrating revenue growth and improved profitability year-over-year. Total revenues reached $35.9 billion, an 11% increase driven by organic Medicaid growth, strong performance in the Medicare segment, and the acquisition of Magellan Health. While the Health Benefits Ratio (HBR) saw a slight increase, operating expenses were managed effectively, leading to a 26% increase in net earnings attributable to Centene Corporation. The company continues to execute its Value Creation Plan, focusing on SG&A savings, gross margin expansion, and strategic capital management. Significant progress has been made in real estate optimization, resulting in cost savings and the divestiture of non-core assets like PANTHERx Rare. The company also returned capital to shareholders through substantial stock and debt repurchases, underscoring a commitment to shareholder value. Looking ahead, Centene is well-positioned to navigate the evolving healthcare landscape, including the upcoming Medicaid redeterminations and continued expansion of its Ambetter Health Marketplace product. Despite ongoing operational and regulatory complexities, the company's diversified business model and strategic initiatives provide a foundation for sustainable growth and profitability.

Centene Corporation (CNC) reported mixed results for the second quarter of 2022. Total revenues saw a significant increase of 16% year-over-year, reaching $35.9 billion, driven by strong growth in its Medicaid and Medicare businesses, along with contributions from recent acquisitions like Magellan Health. However, the company posted a net loss of $171 million ($0.29 per diluted share), a substantial improvement from the prior year's loss of $535 million ($0.92 per diluted share). This loss was largely attributable to a significant $1.45 billion real estate impairment charge related to a portfolio optimization initiative. Despite the reported net loss, adjusted diluted EPS was $1.77, showing considerable growth from $1.25 in the prior year's quarter, indicating underlying operational strength. The company also demonstrated robust operating cash flow of $3.4 billion for the quarter. Centene continues to execute its value creation plan, focusing on SG&A savings, gross margin expansion, and strategic capital management, including significant portfolio adjustments such as the sale of PANTHERx and planned divestitures of Magellan Rx and international operations.

Centene Corporation (CNC) reported a strong first quarter of 2022, with total revenues surging 24% year-over-year to $37.2 billion, driven by robust growth across its Medicaid and Medicare segments, as well as contributions from recent acquisitions. The company's strategic initiatives, including its Value Creation Plan focused on SG&A savings and margin expansion, are showing traction. The acquisition of Magellan Health in January 2022 is a significant development, aimed at enhancing integrated healthcare solutions and is expected to contribute to future growth, though it also led to an increase in SG&A expenses in the current quarter. Despite a slight increase in the health benefits ratio (HBR) to 87.3%, the company's profitability improved, with diluted EPS rising 21% to $1.44. Operating cash flows were notably strong at $1.2 billion. Centene continues to expand its membership across its core government-sponsored programs and is actively managing its capital through share repurchases and strategic investments. While navigating the ongoing uncertainties of the COVID-19 pandemic and regulatory landscapes, Centene appears well-positioned for continued growth and value creation.

Centene Corporation's (CNC) third-quarter 2021 filing shows robust revenue growth driven by expansion in Medicaid and Medicare programs, alongside strategic acquisitions like Circle Health and PANTHERx. Total revenues increased by 11% year-over-year to $32.4 billion, reflecting strong membership growth, particularly in Medicaid, which benefited from the ongoing suspension of eligibility redeterminations. The company also saw an increase in Medicare membership and successfully integrated recent acquisitions. Despite revenue growth, net earnings attributable to Centene Corporation saw a decrease of 59% to $748 million for the nine months ended September 30, 2021, compared to $1.82 billion in the prior year. This decline was significantly impacted by a substantial $1.25 billion legal settlement reserve related to Envolve Pharmacy Solutions and a $229 million impairment charge on the RxAdvance investment. The company's operating expenses, particularly medical costs, increased, leading to a higher Health Benefits Ratio (HBR). However, the selling, general, and administrative (SG&A) expense ratio improved due to revenue leverage and the absence of a large charitable contribution made in the prior year.

Centene Corporation (CNC) reported its second quarter and first six months of 2021 financial results, showcasing revenue growth driven by expansion in its Medicaid and Medicare segments, partly offset by the repeal of the health insurer fee. Total revenues grew 12% year-over-year in Q2 2021 to $31.0 billion. However, the company experienced a significant net loss of $535 million in Q2 2021, primarily due to a $1.25 billion legal settlement reserve related to its pharmacy benefits manager subsidiary, Envolve Pharmacy Solutions. This legal settlement significantly impacted diluted loss per share, resulting in a loss of $0.92 per share for the quarter. The company continues to expand its membership, particularly in Medicaid, which saw a 0.8 million member increase year-over-year in its managed care business. Strategic acquisitions, such as PANTHERx and Apixio, are contributing to revenue growth and expanding capabilities. Centene is also progressing with its planned acquisition of Magellan Health, which is expected to close in the second half of 2021. Despite the Q2 net loss driven by the legal settlement, the company highlighted strong operating cash flows of $1.7 billion for the quarter.

Centene Corporation (CNC) reported strong financial performance for the first quarter of 2021, with total revenues reaching $30.0 billion, a 15% increase year-over-year, driven by a full quarter of WellCare results and continued suspension of Medicaid eligibility redeterminations. The company also saw significant improvements in profitability, with diluted earnings per share (EPS) rising to $1.19 from $0.08 in the prior year period, and adjusted diluted EPS increasing to $1.63. This performance was supported by a lower Health Benefits Ratio (HBR) of 86.8% and a reduced Selling, General & Administrative (SG&A) expense ratio of 8.4%, reflecting improved operational efficiencies and the repeal of the Health Insurer Fee (HIF). Key growth drivers included strategic acquisitions like Apixio and PANTHERx, expansion in the Health Insurance Marketplace, and increased Medicaid membership. The company also provided positive outlook for future growth, anticipating benefits from ongoing acquisitions, the extension of the Health Insurance Marketplace special enrollment period, and new contract wins. Centene remains focused on its acquisition of Magellan Health, expected to close in the second half of 2021, which aims to broaden its whole health capabilities. Despite some headwinds such as a delay in premium payments from New York and a decrease in Medicare Star quality ratings, the company's robust revenue growth and enhanced profitability highlight its strategic execution and market position.

Centene Corporation's (CNC) Q3 2020 10-Q filing reveals a period of significant growth and strategic integration, largely driven by the acquisition of WellCare Health Plans, Inc. Total revenues surged by 53% year-over-year for the quarter, reaching $29.1 billion, primarily due to the consolidation of WellCare's operations and increased membership across its government-sponsored healthcare programs. The company demonstrated robust membership growth, increasing by 9.9 million members (65%) year-over-year, indicating successful expansion and strong demand for its health insurance offerings. The company reported a notable improvement in profitability, with net earnings attributable to Centene Corporation increasing by 498% to $568 million for the quarter, and diluted EPS rising to $0.97 from $0.23 in the prior year. This growth was supported by favorable adjustments, including a significant benefit from the ACA risk corridor receivable settlement and lower medical utilization due to the COVID-19 pandemic, partially offset by a substantial charitable contribution commitment. The balance sheet reflects the scale of the WellCare acquisition, with total assets more than doubling to $68.4 billion, driven by increases in goodwill and intangible assets. Despite increased debt related to the acquisition, the company's liquidity position remains adequate.

Centene Corporation (CNC) reported strong revenue growth of 51% year-over-year for the second quarter of 2020, reaching $27.7 billion. This growth was primarily driven by the successful acquisition of WellCare Health Plans, Inc. and increased membership across its Medicaid, Medicare, and Health Insurance Marketplace offerings. Despite the revenue surge, the company navigated challenges related to the COVID-19 pandemic, which notably led to a decrease in medical utilization, thereby improving the Health Benefits Ratio (HBR) to 82.1% from 86.7% in the prior year period. This decrease in utilization, coupled with a more favorable SG&A expense ratio, contributed to a significant increase in net earnings attributable to Centene Corporation, which grew by 144% to $1.2 billion, or $2.05 per diluted share.

Centene Corporation (CNC) reported its first quarter 2020 results, marked by the significant completion of the WellCare Health Plans, Inc. acquisition on January 23, 2020. This transformative acquisition more than doubled the company's size and significantly expanded its Medicare and Medicaid offerings. Total revenues surged by 41% year-over-year to $26.0 billion, primarily driven by the WellCare integration, health insurer fee reinstatement, and organic growth in various programs. Despite revenue growth, net earnings attributable to Centene Corporation saw a substantial decrease to $46 million from $522 million in the prior year's quarter, largely due to increased acquisition-related expenses and debt extinguishment costs associated with the WellCare acquisition. The company also experienced a negative operating cash flow of $240 million, impacted by a delay in New York premium payments and working capital needs from its Medicare Prescription Drug Plan business. The company's balance sheet reflects the impact of the acquisition, with total assets growing significantly. However, liabilities also increased considerably, particularly long-term debt, to finance the transaction. Management highlighted the ongoing uncertainties related to the COVID-19 pandemic, including potential impacts on membership, utilization trends, and investment income. Despite these challenges and the near-term earnings impact of the acquisition, Centene maintained its full-year Adjusted diluted EPS guidance, reflecting confidence in its long-term strategy and operational resilience.

Centene Corporation (CNC) reported strong revenue growth in the third quarter of 2019, with total revenues increasing by 17% year-over-year to $19.0 billion, driven by membership growth across its Medicaid, Commercial, and Health Insurance Marketplace segments, as well as strategic acquisitions. Despite revenue expansion, the Health Benefits Ratio (HBR) increased to 88.2%, primarily due to the absence of the Health Insurer Fee (HIF) in 2019 and specific state-directed payments. Notably, the company recorded a significant non-cash goodwill and intangible asset impairment of $271 million, largely related to its USMM physician home health business, which impacted reported earnings per share. However, adjusted diluted EPS showed a modest increase to $0.96 from $0.89 in the prior year. The company continues to advance its significant acquisition of WellCare, with key regulatory approvals progressing and an expected closing in the first half of 2020. This strategic move is anticipated to be accretive to earnings. Centene's balance sheet reflects increased assets and liabilities compared to the prior year, with a focus on managing its investment portfolio and debt levels as it prepares for the WellCare integration. The company maintains sufficient liquidity and remains compliant with its debt covenants.

Centene Corporation (CNC) reported solid growth in its second quarter and first half of 2019, driven by strategic acquisitions and organic membership expansion. Total revenues significantly increased year-over-year, reflecting the successful integration of Fidelis Care and growth across its Medicaid, Medicare, and Health Insurance Marketplace segments. The company's focus on expanding its national footprint and diversifying its service offerings continues to yield positive results in revenue generation. Despite topline growth, investors should note a slight increase in the Health Benefits Ratio (HBR), primarily attributed to the normalization of margins in the Health Insurance Marketplace and the inclusion of Fidelis Care, which operates at a higher HBR. However, this was partially offset by improved Selling, General, and Administrative (SG&A) expense ratios, also influenced by the Fidelis Care acquisition. The company is actively managing its expenses and demonstrating operational efficiency. The upcoming acquisition of WellCare remains a key strategic initiative, with shareholder approvals secured and integration planning underway, signaling a significant potential for future value creation, albeit with associated integration risks and financing considerations.

Centene Corporation's (CNC) first quarter 2019 filing reveals robust revenue growth, driven significantly by the acquisition of Fidelis Care and expansions in various states and product lines, most notably the Health Insurance Marketplace. Total revenues surged by 40% year-over-year to $18.4 billion. The company demonstrated strong membership growth, increasing its managed care membership by 14% to 14.7 million. While the health benefits ratio (HBR) saw a slight increase to 85.7%, the selling, general, and administrative (SG&A) expense ratio improved to 9.6% due to the Fidelis Care acquisition. Diluted earnings per share (EPS) rose to $1.24 from $0.96 in the prior year's quarter. A significant development during the quarter was the announcement of a definitive agreement to acquire WellCare Health Plans, Inc. for approximately $17.3 billion, a move expected to further solidify Centene's market position. Centene continues to navigate a complex regulatory landscape with a focus on delivering affordable healthcare. The company's liquidity remains strong, supported by operating cash flows and available credit facilities. The pending WellCare acquisition represents a major strategic initiative that, if completed, is expected to significantly reshape the company's scale and market presence in the managed care sector.

Centene Corporation (CNC) reported significant revenue growth in the third quarter and first nine months of 2018, primarily driven by the substantial acquisition of Fidelis Care. Total revenues increased by 36% year-over-year for the quarter and 22% for the nine-month period. Despite this revenue expansion, net earnings attributable to Centene Corporation declined significantly, primarily due to acquisition-related expenses, particularly the $324 million charitable contribution commitment related to the Fidelis Care acquisition, and costs associated with the expiration of the Veterans Affairs contract. The company's balance sheet shows a considerable increase in total assets, growing from $21.9 billion at year-end 2017 to $31.2 billion by September 30, 2018, largely due to the acquisition. This is reflected in higher goodwill, intangible assets, and investments. The acquisition also led to an increase in both current and long-term liabilities. Managed care membership also saw a significant increase of 17% year-over-year, reaching 14.4 million members.

Centene Corporation (CNC) reported strong revenue growth and improved profitability in its second quarter and first half of 2018, driven by expansion in its Health Insurance Marketplace business and strategic acquisitions. Total revenues increased by 19% year-over-year for the quarter and 16% for the first half. Net earnings attributable to Centene Corporation saw a significant increase of 18% for the quarter and 63% for the first half, indicating successful operational execution and integration of new business lines. The company also successfully closed the significant acquisition of Fidelis Care New York on July 1, 2018, which is expected to further expand its market presence. Despite ongoing investments and integration efforts, Centene demonstrated solid financial performance and a robust liquidity position.

Centene Corporation (CNC) reported a strong first quarter in 2018, demonstrating robust revenue growth and improved profitability. Total revenues increased by 13% year-over-year to $13.2 billion, driven by expansions in various state programs, growth in the Health Insurance Marketplace, and the reinstatement of the health insurer fee. The company also saw a significant improvement in its health benefits ratio (HBR) to 84.3% from 87.6% in the prior year, indicating better management of medical costs relative to premium revenues. Diluted EPS surged to $1.91 from $0.79 in the same period last year, reflecting operational efficiencies and strategic growth initiatives. Key operational highlights include a 6% increase in managed care membership to 12.8 million. The company continued its acquisition strategy, completing the acquisition of Community Medical Group (CMG) and expanding its ownership in Interpreta. Additionally, Centene made a strategic investment in RxAdvance, a pharmacy benefit manager, signaling a commitment to technological innovation and integrated services. The company is also progressing with its significant Fidelis Care acquisition, which is expected to close around July 1, 2018, subject to regulatory approvals.

Centene Corporation's Q3 2017 filing shows robust top-line growth driven by increased membership, particularly in government-sponsored programs. Total revenues reached $11.9 billion, a 10% increase year-over-year, fueled by an 8% rise in managed care membership to 12.3 million. The company reported net earnings attributable to Centene Corporation of $205 million for the quarter, a significant increase from $147 million in the prior year. Diluted EPS also saw a healthy jump to $1.16 from $0.84. This performance was supported by an 88.0% health benefits ratio (HBR) and an improved selling, general, and administrative (SG&A) expense ratio of 9.0%. A notable event is the definitive agreement to acquire Fidelis Care for $3.75 billion, expected to close in early 2018, which is poised to expand Centene's presence in New York. The company continues to navigate regulatory trends and uncertainties, including potential changes to the Affordable Care Act, while demonstrating its capacity to grow and adapt.

Centene Corporation (CNC) reported strong revenue growth in the second quarter and first half of 2017, driven primarily by the acquisition of Health Net and expansion in various state programs and the Health Insurance Marketplace. Total revenues for the second quarter increased by 10% year-over-year to $12.0 billion, and for the six months ended June 30, 2017, revenues grew by 33% to $23.7 billion. The company experienced significant membership growth, increasing its managed care membership by 7% year-over-year to over 12.2 million members. Net earnings attributable to Centene Corporation also saw substantial increases, with a 49% rise in the second quarter to $254 million ($1.44 diluted EPS) and a 155% increase for the first half to $393 million ($2.23 diluted EPS). While medical costs increased in line with revenue, the health benefits ratio (HBR) remained stable and slightly improved year-over-year. The company also benefited from the moratorium on the Health Insurer Fee for 2017, which positively impacted its income tax expense and effective tax rate. Financially, Centene demonstrated solid operational cash flow generation of $942 million for the first six months of 2017, a significant improvement from the prior year. The company's liquidity position remains strong, with a positive working capital of $682 million as of June 30, 2017. Despite increased debt levels due to the Health Net acquisition, Centene remains compliant with its debt covenants.

Centene Corporation (CNC) reported a significant turnaround in its financial performance for the first quarter of 2017 compared to the same period in 2016. Total revenues surged by 69% to $11.7 billion, primarily driven by the acquisition of Health Net completed in March 2016, along with organic growth from new programs and expansion in the Health Insurance Marketplace. The company also demonstrated strong operational efficiency improvements, with the health benefits ratio (HBR) decreasing to 87.6% from 88.7% year-over-year. This improvement is attributed to the Health Net acquisition's favorable mix of commercial business and growth in the Health Insurance Marketplace. Centene reported a substantial increase in operating cash flows to $1,248 million, up from $196 million in the prior year, reflecting improved earnings and effective working capital management. Financially, Centene has transitioned from a net loss of $(16) million in Q1 2016 to a net earning of $139 million in Q1 2017. Diluted EPS also showed a dramatic improvement, rising from $(0.13) to $0.79. The company's balance sheet shows total assets increased to $21.4 billion from $20.2 billion, supported by increased cash and cash equivalents and a robust investment portfolio. Management highlighted strong membership growth and strategic expansion initiatives as key drivers for future growth.

Centene Corporation's (CNC) Q3 2016 report highlights significant growth driven primarily by the acquisition of Health Net, Inc., completed in March 2016. Total revenues surged by 86% year-over-year for the quarter and 74% for the first nine months, reaching $10.8 billion and $28.7 billion, respectively. This revenue growth was accompanied by a substantial increase in managed care membership, which more than doubled to 11.4 million. The company successfully integrated Health Net's operations, contributing to expanded Medicaid and Medicare offerings and diversification across new markets. Despite the impressive top-line growth, investors should note the significant increase in debt and the associated rise in interest expenses, largely due to financing the Health Net acquisition. The company's general and administrative expenses also saw a substantial rise, partly due to acquisition-related costs and integration efforts. While net earnings attributable to Centene Corporation increased by 56% to $145 million for the quarter, diluted EPS saw a slight decrease year-over-year due to a larger share base post-acquisition and the impact of acquisition-related expenses. The company continues to navigate a complex regulatory environment, with ongoing focus on managing medical costs and adapting to evolving healthcare policies.

Centene Corporation reported strong revenue growth in the second quarter and first half of 2016, primarily driven by the significant acquisition of Health Net, Inc. This acquisition, completed in March 2016, dramatically increased the company's membership and operational scale. While revenues surged due to the integration of Health Net, the company also incurred substantial acquisition-related expenses and increased its debt load to finance the transaction. Despite the integration complexities and increased leverage, Centene demonstrated improved operational efficiency, with a lower health benefits ratio compared to the prior year, partially due to Health Net's more favorable business mix. The company's strategic focus on expanding its government-sponsored healthcare programs, coupled with the significant growth from the Health Net acquisition, positions it for continued expansion, although near-term financial results reflect the costs and integration efforts associated with this major strategic move.

Centene Corporation (CNC) reported significant changes in its first quarter 2016 results, largely driven by the transformative acquisition of Health Net, Inc. on March 24, 2016. This acquisition immediately impacted the company's financial statements, adding eight days of Health Net's operations and substantially increasing its membership base by 162% year-over-year to 11.5 million. Total revenues saw a robust 36% increase to $7.0 billion, primarily fueled by expansions, new programs, and the Health Net acquisition. However, the quarter resulted in a net loss of $17 million, or $(0.14) per diluted share, a sharp contrast to the prior year's net earnings of $63 million. This loss was significantly influenced by $189 million in Health Net acquisition-related expenses, which included investment banking fees, charitable contributions, and employee termination costs. Excluding these one-time expenses and intangible asset amortization, Adjusted Diluted EPS stood at $0.74, compared to $0.55 in the prior year, indicating underlying operational improvements amidst the integration. Financially, the company experienced a substantial increase in total assets, from $7.3 billion to $18.7 billion, reflecting the acquisition. Long-term debt also surged to $4.3 billion from $1.2 billion, primarily to fund the Health Net transaction. Operating cash flow strengthened to $195 million, a significant improvement from $45 million in the prior year, suggesting healthy cash generation from core operations despite the acquisition-related costs. Investors should note the company's strategic pivot towards growth through acquisitions, the substantial integration efforts underway, and the impact of these on short-term profitability. The company's future performance will depend on its ability to successfully integrate Health Net, realize expected synergies, and manage its expanded operational footprint while navigating the complexities of government-sponsored healthcare programs.

Centene Corporation (CNC) reported robust financial performance for the third quarter and the first nine months of 2015, driven by significant membership growth across its managed care segments. Total revenues grew substantially year-over-year, reflecting expansions in key states and new program implementations. The company's Health Benefits Ratio (HBR) remained strong, demonstrating effective cost management. However, General and Administrative (G&A) expenses saw an increase, partly due to merger-related expenses for the anticipated acquisition of Health Net, Inc., and operational investments to support membership expansion. Financially, Centene saw a healthy increase in net earnings attributable to common shareholders, alongside growth in diluted earnings per share. The company's balance sheet strengthened with a notable increase in total assets, primarily driven by higher premium receivables and investments. The company also advanced its strategic growth initiatives, including significant acquisitions and expansion into new markets. Looking ahead, Centene is progressing with its planned acquisition of Health Net, which is expected to close in early 2016, and is confident in its ability to fund its operations and strategic initiatives.

Centene Corporation (CNC) demonstrated robust growth in the second quarter and first half of 2015, driven by significant expansion in its managed care membership and service revenues. Total revenues for the first half of the year reached $10.6 billion, a 42.1% increase year-over-year, with premium and service revenues growing by 40.2% to $9.9 billion. This growth was fueled by new and expanded programs in states like Florida, Illinois, Louisiana, and Texas, leading to a 38% year-over-year increase in managed care membership to over 4.6 million by June 30, 2015. The company also announced a significant subsequent event: a definitive agreement to acquire Health Net, Inc. for approximately $6.8 billion, expected to close in early 2016. This strategic move signals a strong focus on future expansion and market consolidation. Despite increased medical costs, which rose 41% year-over-year for the first half, the company managed its Health Benefits Ratio to 89.4%, a slight increase from 89.1% in the prior year, indicating effective cost management within its core operations. Diluted EPS for the first half was $1.23, a substantial increase from $0.69 in the prior year.

Centene Corporation (CNC) reported significant growth in its first quarter 2015 results, demonstrating robust expansion across its managed care operations. Total revenues surged by 48.3% year-over-year to $5.13 billion, largely driven by a substantial 42% increase in premium and service revenues, which reached $4.76 billion. This growth was fueled by expanded program participation in key states like Florida, Illinois, and Ohio, as well as new contracts and market entries. The company's membership base grew by an impressive 44% to 4.4 million members compared to the prior year. Net earnings attributable to Centene Corporation more than doubled, reaching $63 million ($0.51 diluted EPS) for the quarter, compared to $33 million ($0.28 diluted EPS) in the first quarter of 2014. This demonstrates the company's ability to leverage its expanding scale, with operating expenses growing at a slower pace than revenues. The health benefits ratio remained stable at 89.8%, indicating effective cost management. Despite a year-over-year decrease in operating cash flow from $252 million to $45 million, primarily due to timing differences in state payments, the company maintains a strong liquidity position and is well-positioned for continued growth.

Centene Corporation (CNC) demonstrated significant year-over-year growth in its third quarter 2014 report, driven by strong membership increases across its managed care segments. Total revenues surged by 55.7% to $4.35 billion for the quarter, and by 49.2% to $11.84 billion for the nine months ended September 30, 2014. This growth was fueled by strategic expansions in key states like Florida, Ohio, and Washington, participation in Health Insurance Marketplaces, and the acquisition of U.S. Medical Management. The company's financial performance reflects a robust expansion strategy, with total assets growing significantly to $5.45 billion as of September 30, 2014, up from $3.53 billion at the end of 2013. This asset growth is supported by substantial increases in both current and long-term assets, including significant goodwill resulting from recent acquisitions. Profitability also saw a healthy increase, with net earnings attributable to Centene Corporation rising 67.3% to $82.7 million for the third quarter. The company's strong operating cash flow of $853.7 million for the nine months ended September 30, 2014, underscores its ability to fund its aggressive growth initiatives.

Centene Corporation (CNC) reported strong financial performance for the six months ended June 30, 2014, demonstrating significant growth in revenues and earnings. Total revenues increased by 45.7% year-over-year to $7.5 billion, driven by robust expansion across various states and participation in Health Insurance Marketplaces. This revenue growth was underpinned by a substantial increase in at-risk managed care membership, up 23% year-over-year. The company also showed improved operational efficiency, with the General and Administrative (G&A) expense ratio decreasing slightly year-over-year. Net earnings attributable to Centene Corporation common shareholders saw a healthy increase of 31.0% to $81.8 million for the first half of the year. The company successfully integrated key acquisitions, notably U.S. Medical Management, and continues to execute its growth strategy through new contracts and market expansions, positioning it well for future performance. While the company experienced an increase in its Health Benefits Ratio (HBR) due to higher acuity membership, it effectively managed other operating expenses. The company also navigated the impact of the Affordable Care Act (ACA) health insurer fee, largely offsetting its net cost through state reimbursement agreements. Centene's strong operating cash flow and strategic debt management indicate a solid liquidity position to support ongoing operations and future growth initiatives.

Centene Corporation (CNC) reported strong financial performance for the first quarter ended March 31, 2014, with significant year-over-year growth in total revenues, driven by expanded operations in various states, new contracts, and strategic acquisitions. The company saw a substantial increase in premium and service revenues, up 38.4%, reaching $3.35 billion. This growth was fueled by expanding its reach in Florida, Ohio, California, New Hampshire, and securing new contracts, alongside the acquisitions of AcariaHealth and U.S. Medical Management (USMM). Profitability also improved, with net earnings attributable to Centene Corporation increasing by 43.4% to $33.0 million, resulting in diluted earnings per share of $0.56. The company successfully managed its medical costs, with the Health Benefits Ratio (HBR) improving to 89.3% from 90.2% in the prior year, attributed to lower flu costs and reduced utilization due to inclement weather. Operating cash flow saw a significant surge to $252.4 million, up from $43.0 million in the same period last year, underscoring robust operational performance and effective working capital management.

Centene Corporation (CNC) reported solid financial performance for the nine months ended September 30, 2013. Total revenues grew by 30.4% year-over-year to $8.175 billion, driven by expansions in key states like Texas, Mississippi, and Florida, as well as strategic acquisitions. The company demonstrated improved operational efficiency, with its Health Benefits Ratio (HBR) decreasing to 88.9% for the nine-month period, down from 91.7% in the prior year, indicating better management of medical costs relative to premium revenues. Net earnings attributable to Centene Corporation turned positive, reaching $111.8 million for the nine months ended September 30, 2013, a significant turnaround from a net loss of $7.2 million in the same period of 2012. This profitability reflects successful integration of new contracts and acquisitions, coupled with strategic operational improvements. The company's balance sheet strengthened, with total assets increasing to $3.139 billion, supported by growth in goodwill and intangible assets, reflecting the impact of acquisitions like AcariaHealth.

Centene Corporation (CNC) reported a strong rebound in its financial performance for the second quarter and first half of 2013 compared to the prior year. Total revenues grew significantly, driven by a substantial increase in premium and service revenues, up 27.8% for the quarter and 39.0% for the first six months. This growth was fueled by new contract wins and expansions in several states, including Kansas, Louisiana, Mississippi, Missouri, Texas, and Washington, as well as the strategic acquisition of AcariaHealth, Inc. The company also demonstrated improved operational efficiency, with a notable decrease in its Health Benefits Ratio (HBR) to 88.8% for the quarter, down from 92.9% in the prior year, indicating better management of medical costs relative to premium revenues. While General and Administrative (G&A) expenses saw an increase, the G&A expense ratio remained relatively stable, benefiting from revenue leverage. These factors contributed to a significant turnaround in earnings from operations, shifting from a loss in the prior year to a healthy profit in the current periods.

Centene Corporation's (CNC) Q1 2013 filing shows robust revenue and membership growth, driven by significant expansions in states like Texas, Mississippi, and Louisiana, as well as new contracts in Kansas and Missouri. Total revenues surged by 54.5% year-over-year to $2.65 billion, with premium and service revenues up 52.8%. Membership increased by a substantial 25% to nearly 2.7 million at-risk members. While the company experienced increased medical costs (Health Benefits Ratio of 90.4% vs. 88.2% in Q1 2012), largely attributed to higher flu costs and new business expenses, it effectively managed its General and Administrative expense ratio, which improved to 8.3% from 9.8% due to leveraging expenses over higher revenue. Operating cash flow turned positive, reaching $43 million, a significant improvement from a negative $32.1 million in the prior year's quarter, indicating better operational cash generation. The company also announced the acquisition of AcariaHealth, a specialty pharmacy, and several strategic contract wins and expansions expected to fuel future growth.

Centene Corporation's (CNC) Q3 2012 10-Q filing reveals a period of significant growth accompanied by operational challenges. The company experienced substantial revenue increases, driven by aggressive expansion into new states and increased membership, particularly within its Medicaid Managed Care segment. However, this growth came at the cost of a significantly higher Health Benefits Ratio (HBR), largely due to a substantial premium deficiency reserve established for its Kentucky operations and increased medical costs in new expansion areas. Key financial highlights include strong top-line growth and improved G&A expense ratios. However, the company reported a net loss for the nine-month period ended September 30, 2012, a stark contrast to the prior year's profit, primarily impacted by the Kentucky reserve, an impairment loss on goodwill and intangibles, and increased medical costs. Despite these challenges, Centene demonstrated robust operating cash flow and maintains a solid liquidity position with ample availability under its revolving credit facility, positioning it to fund ongoing growth initiatives.

Centene Corporation (CNC) reported a significant increase in revenues driven by substantial membership growth of 51.7% year-over-year, reaching 2.4 million members by June 30, 2012. This growth was primarily fueled by new contracts and expansions in states like Texas, Louisiana, and Kentucky, alongside the company's existing strong presence in Arizona, Georgia, and Indiana. However, this top-line growth was overshadowed by a substantial increase in medical costs, leading to a consolidated Health Benefits Ratio (HBR) of 92.9% for the quarter, up from 84.8% in the prior year. This surge in medical costs, attributed to expansion areas, retroactive member assignments, and issues with recently acquired individual health policies, resulted in a net loss for the quarter. Furthermore, the company recognized a significant impairment loss of $28 million in the second quarter of 2012, primarily impacting goodwill and intangible assets within the Specialty Services segment. This impairment was driven by higher-than-expected medical costs in its individual health insurance business and the evolving regulatory landscape following the Supreme Court's affirmation of the Affordable Care Act. Despite the operational challenges and the net loss, the company maintained a strong liquidity position and expects continued membership growth in the upcoming periods.

Centene Corporation's first quarter 2012 report shows significant revenue growth driven by an expansion in managed care membership, particularly in Medicaid and CHIP programs. Total revenues increased by 40.8% year-over-year to $1.71 billion, primarily due to new contracts and expanded services in states like Arizona, Illinois, Kentucky, and Louisiana. Despite strong top-line growth, net earnings attributable to Centene Corporation saw a slight decrease of 1.0% to $23.978 million, resulting in diluted earnings per share of $0.45, down from $0.46 in the prior year. The company experienced a notable increase in its Health Benefits Ratio (HBR) to 88.2% from 84.9% in the prior year, mainly attributed to higher medical costs in key markets like Kentucky and Texas. However, this was partially offset by an improvement in the General and Administrative (G&A) expense ratio, which decreased to 9.8% from 12.0%, reflecting better cost leverage over increased revenues and reduced performance-based compensation. Operationally, Centene added 607,000 members year-over-year, reaching a total of 2,149,500 at-risk managed care members. Cash flow from operations turned negative for the quarter at ($32.1) million, impacted by timing differences in premium payments from state customers, a deviation from the $94.0 million positive cash flow in the same period last year. The company maintained a strong regulatory capital position, with statutory capital and surplus significantly exceeding required minimums.

Centene Corporation's (CNC) 10-Q filing for the period ending October 28, 2011, reveals the company is actively managing its contractual relationships and financial obligations. Key exhibits include significant amendments to contracts with the Georgia Department of Community Health and the Texas Health and Human Services Commission, indicating ongoing operational adjustments and potential growth in these state-based programs. The inclusion of the Indenture for its 5.75% Senior Notes due 2017 highlights the company's use of debt financing to support its strategic objectives. Investors should note the company's focus on compliance and financial reporting, as evidenced by the inclusion of the computation of its ratio of earnings to fixed charges. While this filing primarily details contractual agreements and financial structures, it underscores Centene's engagement with government healthcare programs and its established debt instruments, which are crucial components of its operational and financial landscape.

Centene Corporation's (CNC) third-quarter 2011 10-Q filing reveals a company actively managing its financial position and operations. While specific financial figures for the quarter are not detailed in the provided index, the inclusion of Consolidated Balance Sheets, Statements of Operations, and Cash Flows indicates the company is reporting on its financial health. Investors should pay close attention to the Management's Discussion and Analysis (MD&A) for insights into the company's performance drivers, strategies, and outlook.

Centene Corporation's (CNC) 10-Q filing for the period ending June 30, 2011, reveals a company actively engaged in growth and operational management. The report details the company's financial position, including its balance sheets, statements of operations, and cash flows for the first half of the year. Investors should note the significant details within the Management's Discussion and Analysis (MD&A) section, which provides context on the company's performance, financial condition, and outlook. The filing also addresses legal proceedings and risk factors, offering transparency into potential challenges and the company's strategies for managing them.

Centene Corporation (CNC) reported a strong first quarter for 2011, demonstrating significant revenue growth and improved profitability from continuing operations. Total revenues increased by 13.8% year-over-year, driven by a 15.4% rise in premium and service revenues, largely attributed to a 4.8% increase in at-risk managed care membership. The company successfully managed its medical costs, reflected in a lower Health Benefits Ratio (HBR) of 83.0% compared to 84.0% in the prior year, primarily due to decreased utilization. Despite an increase in General and Administrative (G&A) expenses, partly due to new market entries like Mississippi, Centene's earnings from operations saw a substantial 32.0% increase. Diluted earnings per share from continuing operations grew to $0.46 from $0.41, showcasing operational efficiency and growth. The company also reported robust operating cash flows of $94.0 million, a significant improvement from the prior year's negative cash flow, highlighting enhanced working capital management, particularly from increased unearned revenue.

Centene Corporation's (CNC) 10-Q filing for the period ending September 30, 2010, provides investors with a snapshot of the company's financial health and operational performance. The report details the company's financial statements, including balance sheets, statements of operations, and cash flows, offering insights into its revenue generation, cost structure, and asset base. Investors should pay close attention to the Management's Discussion and Analysis (MD&A) section, which explains the financial condition and results of operations, providing context for the numbers presented. This section will be crucial for understanding the drivers of any changes in performance and the company's outlook.

Centene Corporation (CNC) reported a significant increase in total revenues for the six months ended June 30, 2010, reaching $2.145 billion, up 8.8% from the prior year's $1.972 billion. This growth was primarily driven by an 12.8% increase in premium and service revenues to $2.073 billion, reflecting strong membership growth across its various state Medicaid and CHIP programs, along with expansion into new markets like Massachusetts. Despite revenue growth, the company saw a slight increase in its Health Benefits Ratio (HBR) to 83.9% for the six-month period, indicating rising medical costs. Net earnings attributable to Centene Corporation common stockholders increased by 20.9% to $46.8 million for the six months, demonstrating improved profitability amidst expanding operations. However, operating activities used $98.3 million in cash, a notable shift from the prior year's positive cash flow, largely due to timing differences in premium payments from state clients. The company also completed a stock offering, raising approximately $104.5 million, and used a portion to repay its revolving credit facility, strengthening its financial position.